These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17196074)

  • 1. Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.
    Tiddens HA; Geller DE; Challoner P; Speirs RJ; Kesser KC; Overbeek SE; Humble D; Shrewsbury SB; Standaert TA
    J Aerosol Med; 2006; 19(4):456-65. PubMed ID: 17196074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
    Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
    Amirav I; Newhouse MT; Mansour Y
    Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prerequisites for a dry powder inhaler for children with cystic fibrosis.
    Lexmond AJ; Hagedoorn P; Frijlink HW; Rottier BL; de Boer AH
    PLoS One; 2017; 12(8):e0183130. PubMed ID: 28800360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inspiratory flow rate through a dry powder inhaler (Clickhaler) in children with asthma.
    Parry-Billings M; Birrell C; Oldham L; O'Callaghan C
    Pediatr Pulmonol; 2003 Mar; 35(3):220-6. PubMed ID: 12567391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inspiratory flows and volumes in subjects with cystic fibrosis using a new dry powder inhaler device.
    Elkins MR; Robinson P; Anderson SD; Perry CP; Daviskas E; Charlton B
    Open Respir Med J; 2014; 8():1-7. PubMed ID: 24570763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inspiratory Flows and Volumes in Subjects with Non-CF Bronchiectasis Using a New Dry Powder Inhaler Device.
    Elkins MR; Anderson SD; Perry CP; Daviskas E; Charlton B
    Open Respir Med J; 2014; 8():8-13. PubMed ID: 24570764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.
    Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Patzlaff A; Weimann B
    J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):156-163. PubMed ID: 30848695
    [No Abstract]   [Full Text] [Related]  

  • 9. The inhalation characteristics of patients when they use different dry powder inhalers.
    Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
    Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
    Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
    Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
    Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.
    Malmberg LP; Rytilä P; Happonen P; Haahtela T
    Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():257-62. PubMed ID: 20714380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation of peak inspiratory flow through dry powder inhalers in children with stable and unstable asthma.
    Kamps AW; Brand PL; Roorda RJ
    Pediatr Pulmonol; 2004 Jan; 37(1):65-70. PubMed ID: 14679492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Teaching the inhalation manoeuvre to asthmatic children by means of visual feedback].
    Kamin W; Kreplin A
    Pneumologie; 2007 Mar; 61(3):150-6. PubMed ID: 17342574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peak inspiratory flow using 2 different inhalers and a new portable device].
    García-Marcos Alvarez L; Martínez Torres A; Guillén Pérez JJ; Martínez Victoria A
    An Esp Pediatr; 2001 Feb; 54(2):110-3. PubMed ID: 11181205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
    Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
    Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler).
    Engel T; Heinig JH; Madsen F; Nikander K
    Eur Respir J; 1990 Oct; 3(9):1037-41. PubMed ID: 2289551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study.
    Westerman EM; De Boer AH; Le Brun PP; Touw DJ; Roldaan AC; Frijlink HW; Heijerman HG
    J Cyst Fibros; 2007 Jul; 6(4):284-92. PubMed ID: 17185047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new breath actuated dry powder inhaler (Auto-Jethaler)].
    Steiss JO; Heckmann M; Jödicke B; Landmann E; Schüler D; Weber K; Pabst J; Lindemann H
    Klin Padiatr; 2007; 219(2):66-9. PubMed ID: 16878285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.